NCT04754854
Reduction of Blood Recirculation in Veno-Venous ECMO
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Minor Trial completed Show 4 more changesShow less
- Final enrollment: 77 participants (planned 136)
- Primary completion date changed from estimate of Aug 31, 2026 to May 5, 2026
- Secondary endpoints: details revised at 3 of 22 entries
- Site details revised
- Notable Primary completion date: Sep 30, 2024 to Aug 31, 2026
- Study completion date: Sep 30, 2024 to Oct 31, 2026
- Secondary endpoints: 20 to 22
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Successful ECMO blood flow reduction
Timeframe: Once within the first week after initiation of ECMO therapy
Secondary (22)
Recirculation fraction
Arterial blood oxygen content
Extracorporeal blood Flow
Extracorporeal gas flow
Length of ECMO therapy
Show 17 moreShow less
Cannula position and distance
Right heart dysfunction
Length of mechanical ventilation
Complications of ECMO therapy
ICU mortality
ICU length of stay
Incidence of ICU-acquired organ dysfunctions and complications
ECMO blood flow over time
ECMO sweep gas flow over time
Mobility at ICU discharge
Weaning level at ICU discharge
Status of mechanical ventilation at ICU discharge
Level of organ dysfunction at ICU discharge
Level of consciousness at ICU discharge
Level of disease severity
Hospital acquired infections related to ECMO therapy
Bleeding and thrombembolic complications of ECMO therapy
Sites
1 site in 1 country
- Charité - Universitätsmedizin Berlin, Campus Virchow KlinikumBerlin, State of Berlin, Germany